 |
| Performance Figures as of March 31, 2005 |
|
| aap • mebio (according to IFRS) | | Performance Figures | 1.1.-31.03.2005 | 1.1.-31.03.2004 | 1.1.-31.03.2003 | | | | | | Sales | 3,125 | 3,060 | 2,929 | | Total output | 3,527 | 3,565 | 3,327 | | | | | | Special factors | 0 | 0 | 0 | | | | | | Net loss | -65 | -18 | -701 | | Operating income | 6 | 330 | -407 | | | | | | EBITDA | 337 | 773 | 299 | | EBIT | 6 | 352 | -445 | | EBT | -39 | 62 | -828 | | DVFA/SG earnings | -65 | -19 | -701 | | DVFA/SG earnings per Share | 0.00 | 0.00 | -0.15 | | DVFA/SG Cash Earnings | 234 | 219 | -31 | | DVFA/SG Cash Earnings per Share | 0.02 | 0.04 | -0.01 | | | | | | Selected Performance Figures | 31.03.2005 | 31.03.2004 | 31.03.2003 | | | | | | Fixed assets | 8,315 | 12,987 | 24,781 | | Current assets | 9,567 | 10,114 | 13,143 | | Deferred taxes | 2,456 | 3,610 | 1,580 | | Total assets | 20,338 | 26,712 | 39,723 | | | | | | Shareholder's equity | 15,468 | 6,529 | 21,281 | | Minority Interest | 0 | -276 | -253 | | Non-current liabilities | 286 | 459 | 10,105 | | Current liabilities | 4,584 | 19,999 | 8,590 | | | | | | Equity Ratio | 76% | 24% | 54% | | | | | | Employees | 122 | 101 | 106 |
All figures in € 1,000
|
|
|
Print this page
